| No. |
Year |
Title |
Author |
Corresponding |
Journal |
Vol. |
Pages |
| 1 |
2013 |
Identification of physiologically active substances as novel ligands for MRGPRD. |
Uno M, Nishimura S, Fukuchi K, Kaneta Y, Oda Y, Komori H, Takeda S, Haga T, Agatsuma T, Nara F |
Uno M |
J. Biomedi. Biotech. |
59 |
8161 |
| 2 |
2014 |
Identification of a morphogenetic intermediate of the bacteriophage Mu baseplate |
Tsukamoto N, Kanazawa Y, Shimamori Y, Yoshida K, Takeda S |
Takeda S |
Advanced in Microbiology |
4 |
1155 |
| 3 |
2014 |
Diverse signaling systems activated by the sweet taste receptor in human GLP-1-secreting cells. |
Ohtsu Y, Nakagawa Y, Nagasawa Y, Takeda S, Arakawa H, Kojima I |
Kojima I |
Mol. Cell Endocrinol. |
394 |
70 |
| 4 |
2014 |
Mutation analysis and molecular modeling for the investigation of ligand binding modes of GPR84 |
Nikaido Y, Koyama Y, Yoshikawa Y, Furuya T, Takeda S |
Takeda S |
J. Biochem. (Tokyo) |
157 |
311-320 |
| 5 |
2015 |
In vivo and in vitro evaluation of novel μ-opioid receptor agonist compound |
Nikaido Y, Kurosawa A, Saikawa H, Kuroiwa S, Suzuki C, Kuwabara N, Hoshino H, Obata H, Saito S, Saito T, Osada H, Kobayashi I, Sezutsu H, Takeda S |
Takeda S |
Eur. J. Pharmacol, |
767 |
193-200 |
| 6 |
2016 |
Identification and Molecular Docking Studies for Novel Inverse-Agonists of Super Conserved Receptor Expressed in Brain, SREB |
Yanai T, Kurosawa A, Nikaido Y, Nakajima N, Saito T, Osada H, Konno A, Hirai H, Takeda S |
Takeda S |
Genes to Cells |
21 |
717-727 |
| 7 |
2017 |
A novel partial agonist of GPBA reduces blood glucose level in a murine glucose tolerance test |
R. Enomoto, A. Kurosawa, Y. Nikaido, M. Mashika, T. Saheki, N. Nakajima, S. Kuroiwa, M. Otobe, M. Ohsaki, Y. Inoue, N. Kuwabara, O. Kikuchi, T. Kitamura, I. Kojima, Y. Nakagawa, T. Saito, H. Osada, M. Futahashi, H. Sezutsu, S Takeda |
Takeda S |
Eur. J. Pharmacol |
814 |
130-137 |
| 8 |
2018 |
Production of the MAGE-A4 protein using transgenic silkworms and induction of MAGE-A4-specific immune responses |
Y. Motokawa, M. Kokubo, N. Kuwabara, K. Tatematsu, H. Sezutsu, H. Takahashi, K. Sakakura, K. Chikamatsu, S. Takeda, |
Takeda S |
Exp. Ther. Med. |
15 |
2512-2518 |
| 9 |
2018 |
A possible novel mechanism of action of genistein and daidzein for activating thyroid hormone receptor (TR)-mediated transcription. |
W. Ariyani, T. Iwasaki, W. Miyazaki, Y. Lu, S. Takeda, N. Koibuchi |
N. Koibuchi |
Toxicol. Sci. |
164 |
417-427 |
| 10 |
2019 |
GPR31 and GPR151 are activated under acidic conditions. |
M. Mashiko, A. Kurosawa, Y. Tani, T. Tsuji, S. Takeda |
Takeda S |
J. Biochem. |
|
in press |
| 11 |
2019 |
Phage tail fibre assembly proteins employ a modular structure to drive the correct folding of diverse fibres. |
North OI, Sakai K, Yamashita E, Nakagawa A, Iwazaki T, Büttner CR, Takeda S, Davidson AR. |
Takeda S |
Nat Microbiol. |
4 |
1645-1653 |
| 12 |
2019 |
Observation of unexpected molecular binding activity for Mu phage tail fibre chaperones. |
Sakai K, Iwazaki T, Yamashita E, Nakagawa A, Sakuraba F, Enomoto A, Inagaki M, Takeda S. |
Takeda S |
J. Biochem. |
166 |
529-535 |
| 13 |
2020 |
Secretory expression of thyroid hormone receptor using transgenic silkworms and its DNA binding activity. |
Nakaya H, Tatematsu KI, Sezutsu H, Kuwabara N, Koibuchi N,?Takeda S. |
Takeda S |
Protein Expr Purif. |
176 |
105723-105729 |
| 14 |
2020 |
Discovery of small-molecule modulator of heterotrimeric Gi-protein by integrated phenotypic profiling and chemical proteomics. |
Kawamura T, Futamura Y, Shang E, Muroi M, Janning P, Ueno M, Wilke J,?Takeda S, Kondoh Y, Ziegler S, Watanabe N, Waldmann H, Osada H. |
Osada H |
Biosci Biotechnol Biochem. |
84 |
2484-2490 |
| 15 |
2020 |
Staphylococcal Phage in Combination with Staphylococcus Epidermidis as a Potential Treatment for Staphylococcus Aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants. |
Shimamori Y, Mitsunaka S, Yamashita H, Suzuki T, Kitao T, Kubori T, Nagai H,?Takeda S, Ando H. |
Takeda S |
Viruses. |
13 |
7-15 |
| 16 |
2021 |
Isolation and Characterization of a Novel Phage SaGU1 that Infects Staphylococcus aureus Clinical Isolates from Patients with Atopic Dermatitis. |
Shimamori Y, Pramono AK, Kitao T, Suzuki T, Aizawa SI, Kubori T, Nagai H,Takeda S, Ando H. |
Takeda S |
Curr Microbiol. |
78 |
1267-1276 |
| 17 |
2021 |
In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms |
Yamada K,Masuda K, Ida S, Tada H, Bando M, Abe K, Tatematsu K, Sezutsu H, Oyama T, Chikamatsu K, Takeda S. |
Takeda S |
J Mater Sci Mater Med |
32 |
58-67 |
| 18 |
2022 |
Development of novel potent ligands for GPR85, an orphan G protein-coupled receptor expressed in the brain |
Sakai A, Yasui T, Watanave M, Tatsumi R, Yamamoto Y, Takano W, Tani Y, Okamura I, Hirai H, Takeda S. |
Takeda S |
Genes Cells |
27 |
345-355 |
| 19 |
2022 |
Dynamic alterations of circulating T lymphocytes and the clinical response in patients with head and neck squamous cell carcinoma treated with nivolumab, |
Tada H, Takahashi H, Yamada K, Masuda K, Nagata Y, Uchida M, Shino M, Ida S, Mito I, Matsuyama T, Oyama T, Tatematsu K, Sezutsu H, Takeda S, Chikamatsu K. |
Chikamatsu K |
Cancer Immunol. Immunother. |
71 |
851-863 |
